feed,title,long_url,short_url
SeekingAlpha,FDA accepts BeiGene's tislelizumab application in esophageal carcinoma,https://seekingalpha.com/news/3738907,
SeekingAlpha,Zymeworks' zanidatamab shows encouraging antitumor activity in esophageal cancer,https://seekingalpha.com/news/3738906,
